Sign in >>

News items

Search:

News posted by participants

Göttingen (Germany) – Light microscopy is the most popular imaging method in the biological sciences. In particular, studying dynamics opened up an enormous field of application. Meanwhile the diffraction barrier has been overcome by a number of ‘diffraction-unlimited’ nanosco...
Posted about 1 month ago
The software on Monte Carlo simulation of light transport in 3-D voxelized media is released (called MCVM). By using MCVM, researchers can obtain both steady-state and time-resolved light transport properties in biological tissue with realistic shape and structure. MCVM is ful...
Posted 2 months ago
The presence or absence of gender differences in working memory, localized in the prefrontal cortex (PFC), has been debated in a few fMRI studies. However, the hypothesis of gender differences in PFC function has not been elaborated, and comparisons among hemodynamic parameter...
Posted 3 months ago
New methodologies for delivering energy and light in therapeutic and diagnostic applications are catching on, according to the consultants. “It’s delivering microwaves or infrared or ultrasonics — very, very innovative new discoveries in how that energy can be delivered to th...
Posted 9 months ago
Healthcare breakthroughs are happening where light-based scientific disciplines intersect, experts told the House R&D Caucus on 1 December. Policy-makers in Washington, D.C., were advised how government can help accelerate healthcare innovation by R&D leaders from biophotonic...
Posted 9 months ago
An endoscope equipped with an infrared laser and a tiny mirror might one day help physicians diagnose early signs of cancer and other diseases and aid in surgery. A researcher at the University of Florida, Huikai Xie, has designed a prototype device that captures images up to...
Posted 9 months ago
Case Western Reserve University and University Hospitals Case Medical Center have granted to Bioptigen, of Research Triangle Park, N.C ., an exclusive intellectual property licensing agreement for Fourier domain optical coherence tomography (FDOCT), an imaging technology devel...
Posted 10 months ago
Leading-edge advances such as a revolutionary cardiology treatment and noninvasive optical techniques for studying the brain combined with pragmatic discussions on research focus and funding highlighted a two-day inter-institute workshop last week at the National Institutes of...
Posted 11 months ago
Guided Therapeutics, Inc. (OTC:GTHP) contains perhaps one of the most promising medical devices aiming for an annual global $1 billion dollar non-invasive cervical cancer market. Their device LightTouch is a powerful and innovative non-invasive screening device for early dete...
Posted 11 months ago
Quebec, the “little city” on the St. Lawrence River is becoming a regional hub of excellence in biopharmaceuticals and life sciences research, vaccines, diagnostics, optics/photonics, and nutraceuticals. Optics/photonics is an area of particular expertise in Quebec, with a h...
Posted 12 months ago
PinPointe USA Inc., a medical laser company, has received a new round of venture capital to continue its marketing and development domestically and spur growth internationally. Founded in Chico in 2004, PinPointe is developing foot-care therapies. It’s main business is usin...
Posted 12 months ago
MEDFORD/SOMERVILLE, Mass.--There is a growing need for biocompatible photonic components for biomedical applications – from in vivo glucose monitoring to detecting harmful viruses or the telltale markers of Alzheimer's. Optical waveguides are of particular interest because of ...
Posted about 1 year ago
Former ICOB 2009 speaker and participant, Stephen Minger tells Nature why he is leaving academia.
Posted about 1 year ago
TRUCKEE/TAHOE — Tahoe Forest Health System named Thomas D. Hobday as Founding Director of the newly-formed Tahoe Institute for Rural Health Research at an Aug. 7 event. The Tahoe Institute for Rural Health Research is a unique partnership with the University of California,...
Posted about 1 year ago
Release Date: March 23, 2009 BUFFALO, N.Y. A precise, new nanotechnology treatment for drug addiction may be on the horizon as the result of research conducted at the University at Buffalo. Scientists in UB's Institute for Lasers, Photonics and Biophotonics and UB's De...
Posted about 1 year ago
IEEE Journal of Selected Topics in Quantum Electronics invites manuscript submissions in the area of biophotonics. The purpose of this issue of JSTQE is to highlight the recent progress and trends in developing of novel biophotonics technologies. Broad technical areas include ...
Posted about 1 year ago
MUNICH, Germany, July 1, 2009 -- Attendees gave Laser World of Photonics 2009, the leading trade show for optical technologies, the best ratings in the event's history, event organizers Messe München reported. An optimistic outlook for -- and strong interest in -- biophotonics...
Posted about 1 year ago
A recently developed laser fusion technique allows polymers to be attached to metals and ceramics in short cycle times. The process and its capabilities are reviewed together with its growing range of applications.
Posted about 1 year ago
This work presents the design, fabrication, and testing of an original concept for an optical biosensor device intended for use in a microfluidic network. The device uses planar waveguides intersecting a microfludic channel with biofunctionalized patterned sidewalls to detect ...
Posted about 1 year ago
A research team led by a chemist at the Univ. of California, Riverside has fabricated microscopic polymer beads that change color instantly and reversibly when external magnetic fields acting upon the microspheres change orientation.
Posted about 1 year ago
On Jan 21, 2009, Optics Express published online an original paper entitled “Photostimulation of astrocytes with femtosecond laser pulses”, "http://www.opticsinfobase.org/abstract.cfm?URI=oe-17-3-1291":http://www.opticsinfobase.org/abstract.cfm?URI=oe-17-3-1291 from Britton Ch...
Posted over 1 year ago

All News items

TORONTO, ONTARIO--(Marketwire - Aug. 31, 2010) - Theralase Technologies Inc. (TSX VENTURE:TLT) announces its second quarter 2010 financials.
Posted 2 days ago
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination wi...
Posted 3 days ago
Dr. Paul Tinsley and Dr. Timothy Minton of Arnot Health Aesthetics & MediSpa announced a complimentary educational esthetic event in Horseheads, NY. Featured services will include Fractional Skin Resurfacing, Photo Facials, BOTOX® Cosmetic, and other Facial Fillers.
Posted 3 days ago
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Sant Cluster from Toulouse, the two-day meeting i...
Posted 10 days ago
The deadline for entries to this year's Prism Awards is fast approaching: make sure you apply by September 17.
Posted 10 days ago
(PhysOrg.com) -- A technique developed by Macquarie University has proven for the first time that a tiny amount of zinc from sunscreens is absorbed through the skin into the human body, but is not yet able to discern whether the zinc is in nanoparticle form.
Posted 13 days ago
Core and disruptive photonics technologies are in line for more than EUR115 million support under the European Unions information communication technology (ICT) program for 2011-2012.
Posted 14 days ago
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation awarded 2010 Toshiba America Medical Systems/RSNA grants to Kenneth S. Lee, M.D., Nitin Ohri, M.D., and Ben Paxton, M.D. The grants are made possible by Toshiba's support of the RSNA R&E Fou...
Posted 16 days ago
NICE has published its clinical guideline on the use of ablative therapies for the treatment of Barrett's oesophagus. Ablative therapies destroy the abnormal cells within the oesophagus (sometimes known as the gullet, it is the muscular tube through which food passes from the ...
Posted 17 days ago
The Chief Scientist added the company to the Biomedical Photonics program led by Given Imaging and Medigus.
Posted 17 days ago
Dr. Gene Overholt co-authored an article published last year in The New England Journal of Medicine that does more than detail the 73-year-old physician's participation in a national study about a promising treatment for Barrett's esophagus.
Posted 18 days ago
EntreMed, Inc.,a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and six-month periods ending June 30, 2010.
Posted 18 days ago
Age-related macular degeneration (AMD) is an eye condition that usually affects those aged 45 and above. People with AMD experience blurred central vision and are unable to see clearly what is in front of them.
Posted 20 days ago
Billionaire investor Charles Brandes just reported the portfolio holdings of his firm. These are the details of buys and sells. Read more
Posted 21 days ago
Biofrontera AG / Biofrontera received manufacturing and distribution license processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
Posted 21 days ago
Tracy High School physics teacher Dean Reese could have taught his students about global warming with a lecture or had them read about it from a textbook.
Posted 22 days ago
An online method for functional monitoring and follow-up of treatment progression of a therapeutic modality based on Blood Oxygenation Level-Dependent (BOLD)-magnetic resonance imaging (MRI).
Posted 22 days ago
Reportlinker.com announces that a new market research report is available in its catalogue:
Posted 23 days ago
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today released financial results for the second quarter 2010, ended June 30, 2010.
Posted 23 days ago
DUSA Pharmaceuticals, Inc. reported that on the afternoon of August 5, 2010 the US Food and Drug Administration (FDA) notified DUSA that it has not granted Orphan Drug Designation for the use of Levulan (aminolevulinic acid HCl) Photodynamic Therapy (PDT) for the prevention of...
Posted 23 days ago
DUSA Pharmaceuticals Inc. has failed to receive orphan drug designation from the FDA for its Levulan Photodynamic Therapy (PDT) system for multiple medical indications, with a concentration on dermatology. As a result, the company will close out the its associated pilot clinic...
Posted 27 days ago
DUSA Pharmaceuticals, Inc. reported today that on the afternoon of August 5, 2010 the U.S. Food and Drug Administration notified DUSA that it has not granted Orphan Drug Designation for the use of Levulan (aminolevulinic acid HCl) Photodynamic Therapy for the prevention of cut...
Posted 27 days ago
According to an Australian Melanoma Family study, use of sunbeds to get a tan can increase the risk of developing melanoma by 41 per cent. The study looked into the effects of sunbeds on 18-39-year-olds and found that 23 per cent of participants who had melanoma reported using...
Posted 28 days ago
It is always reassuring when a facialist has flawless skin. We've scrutinised Sarah Chapman up close and we can tell you she has a preternaturally youthful glow. So we're very hopeful her latest innovation, the Skinesis High Definition facial, will imbue us with a similar lumi...
Posted about 1 month ago
A new study of breast cancer survivors may help physicians ease a common side effect of cancer treatments. The collaborative research by Eva Sevick, Ph.D., Director of the Center for Molecular Imaging at the University of Texas Health Science Center in Houston, and Caroline Fi...
Posted about 1 month ago
LightPath Technologies -- Positioned to Exploit a $1.5 Billion Industry -- Is Presenting Its Expanded Glass Catalog, August 3rd Through 5th, at the SPIE Optics & Photonics Conference in San Diego
Posted about 1 month ago
DUSA Pharmaceuticals, Inc., a dermatology company that is developing and marketing Levulan Photodynamic Therapy and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the second quarter ended June 3...
Posted about 1 month ago
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE (nanoparticle albumin-bound paclitax...
Posted about 1 month ago
Dr. Jeffrey Raval of Denvers Rocky Mountain Laser Aesthetics says most women can find beauty benefits in a safer, more economical and non-invasive way through the latest medical laser technologies now deployed in his clinic.
Posted about 1 month ago
A Fife-based medical device firm is to roll out its lead skin cancer treatment product after raising 1.7m in funding.
Posted about 1 month ago

Send feedback about this page
Email a link to this page

This topic elsewhere

Loading...
Loading...